Overactive Bladder News and Research

RSS

Overactive bladder (OAB) is a urological condition defined by a set of symptoms: "urgency, with or without urge incontinence, usually with frequency and nocturia."

Researchers identify genetic risk for type 1 diabetes

A discovery at the Barbara Davis Center for Childhood Diabetes has identified a genetic risk for type 1 diabetes three to four times higher than previously thought possible.

4 Sep 2006

Aspirin may improve men's urinary health and prevent enlarged prostate

Researchers suggest that taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen may improve men's urinary health.

31 Aug 2006

Mayo clinic finds NSAIDs may prevent or delay enlarged prostate

Mayo Clinic researchers have found that taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen may prevent or delay benign prostatic hyperplasia.

30 Aug 2006

Men with enlarged prostate can benefit from Botox injection

When researchers at the Chang Gung University Medical College, Taiwan and the University of Pittsburgh School of Medicine injected botulinum toxin A, or Botox, into the prostate gland of men with benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, they found that it eased symptoms and improved quality of life.

23 May 2006

Researchers reverse juvenile diabetes in animal model

Groundbreaking human clinical trial for type 1 diabetes to start this spring in Pittsburgh - Children's Hospital of Pittsburgh of UPMC researchers reverse juvenile diabetes in animal model; Phase 1 clinical trial approved by FDA.

4 Apr 2006

High-intensity ultrasound waves heats and destroys uterine fibroids

A totally noninvasive procedure using high-intensity ultrasound waves to heat and destroy uterine fibroid tissue significantly relieves fibroid-related symptoms in women, according to the results of a multicenter clinical trial.

7 Dec 2005

As men grow older, bladder function can worsen and the prostate gland may be responsible

Their findings remind patients and their physicians that urination difficulties in men can be better cared for at early onset. Additionally, the study notes that as men age, the possibility increases that they will experience problems with urination.

25 Oct 2005

Another use for Botox - enlarged prostate

Botox, appears to alter specific cellular processes that contribute to prostate enlargement according to new study results presented by researchers from the University of Pittsburgh and Chang Gung Memorial Hospital in Taiwan at the International Continence Society annual meeting in Montreal.

31 Aug 2005

Oral medications may control symptoms of Type II diabetes in children just as well as insulin injections

According to the medical records of 26 children diagnosed with the disease, oral medications reduced levels of a compound in the blood called hemoglobin A1C by an average of 2 percentage points.

15 Aug 2005

Everything may shrink as you get older but your bladder says the same

Many people find as they get older that they need to go to the toilet more frequently, and University of Pittsburgh researchers say this has nothing to do with a shrinking bladder but it is more likely due to an underlying medical condition.

25 May 2005

What should you do - if anything - to treat an enlarged prostate gland?

Called benign prostatic hyperplasia or hypertrophy (BPH), the condition affects most men as they age. About half of men with an enlarged prostate seek medical treatment because of bothersome urinary tract symptoms. These symptoms may include poor urine flow, straining to urinate, frequent urination and urinary urgency.

25 May 2005

Bladder capacity rarely changes as you age

The idea that your bladder shrinks as you get older may be nothing more than an old wives' tale according to a University of Pittsburgh study. The feeling may, however, signal a treatable underlying condition.

25 May 2005

Commonly prescribed incontinence drug may help control symptoms of overactive bladder

When taken orally, trospium chloride not only helps control symptoms of overactive bladder systemically, but according to this study, it also may help control symptoms in the bladder itself when it comes into contact with the bladder walls.

22 May 2005

Less invasive procedure for treatment of uterine fibroids is effective

Women who suffer from the frustrating and painful chronic symptoms of uterine fibroids have a safe and effective alternative to surgery according to new five-year studies presented at an annual meeting of the Society of Interventional Radiology held in April. Studies found that uterine fibroid embolization has a 73 percent success rate at five years.

11 May 2005

Relief for overactive bladder patients

New landmark data (the STAR Study), revealed today from the European Association of Urology in Istanbul, Turkey, show that patients suffering from Overactive Bladder (OAB) syndrome will see considerably better improvements in their symptoms when being treated with the new antimuscarinic drug solifenacin, than on tolterodine ER - an antimuscarinic drug that is widely used.

17 Mar 2005

More dependable, less expensive tool to help detect bladder cancer earlier

Researchers at The University of Texas M. D. Anderson Cancer Center found that a simple test that can be administered and read in the doctor's office was three times more effective than a conventional laboratory test for detecting bladder cancer.

15 Feb 2005

FDA approves Enablex for the treatment of overactive bladder

Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.

22 Dec 2004

Detrol LA significantly reduces symptoms of overactive bladder

Pfizer today announced results of a comprehensive six-year review of efficacy and safety data for Detrol LA (tolterodine tartrate extended release capsules) indicating that Detrol LA significantly reduces symptoms of overactive bladder (OAB) with a low occurrence of side effects, and should be considered first-line therapy.

13 Dec 2004

FDA approves Vesicare (solifenacin succinate) for the treatment of overactive bladder

Vesicare (solifenacin succinate) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of overactive bladder (OAB) with symptoms of urgency, frequency, and urge incontinence.

23 Nov 2004

Prostate cancer treatment leads to declines in sexual and urinary function

Treatment for prostate cancer leads to significant five-year declines in sexual and urinary function, according to a new study. However, general and other specific health-related quality of life factors, such as bowel function, are not affected.

27 Sep 2004